• Join
  • Login
  • Contact

Search abstracts

A description of how and why EPAs were developed in the Netherlands and the USA

  • At: Glasgow (Scotland) (2018)
  • Type: Presentation
  • By: WESTEIN, Marnix (KNMP, The Netherlands)
  • Co-author(s): Marnix Westein:,Knmp - Royal Dutch Pharmacists Association,Den Haag,Netherlands;Utrecht Institute of Pharmaceutical Sciences,Utrecht University,Utrecht,Netherlands
  • Abstract:

    The abstract has already been submitted by Amy Pittenger and/or Lucinda Maine.


  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses